Harnessing the Latent Potential of Radical Migration to Drive Synthetic Innovation
Project Number1R35GM155233-01
Contact PI/Project LeaderNACSA, ERIC
Awardee OrganizationPENNSYLVANIA STATE UNIVERSITY, THE
Description
Abstract Text
Project Summary/Abstract
This proposal will exploit the unique and latent features of radical-mediated migrations to underpin new synthetic
transformations designed to facilitate the discovery and manufacture of medicines. Using this approach, we aim
to make significant advances in olefin difunctionalizations and stereoselective α-functionalizations of carbonyls.
These reaction classes have enormous potential in pharmaceutical synthesis, but technical complications with
their transition-metal catalysts have restricted the products they can directly access. To address these limitations,
we will develop new conceptual platforms that promote these transformations and are compatible with
medicinally valuable motifs that have heretofore presented challenges. In the context of olefin alkyl–arylation
and amino–arylation, we have shown that a radical-migration-based design affords clear improvements over
established strategies. Using this approach, our alkyl–arylation protocol enables (1) the use of mono- to
tetrasubstituted olefins without activating or directing groups, (2) alkylation with diversifiable partners, (3) the
formation of quaternary benzylic centers, (4) the broad use of N-rich heteroaromatic groups, and (5) good
diastereocontrol. All five of these key outcomes are nearly unprecedented in metal-catalyzed alkyl–arylations of
unbiased olefins, and they result directly from the method’s radical-migration-based design. Amino–arylation
features similar advantages. Future work will comprehensively demonstrate the utility of these methods, develop
more accessible reagents, and the introduce a further suite of amino–functionalization reactions. We will also
translate this open-shell approach to the stereoselective α-functionalization of carbonyls. In this setting, we will
develop and implement simple ‘chiral chaperones’ that are well-poised to deliver aromatics and other key
functional groups to the α-position of carbonyl compounds after a radical-generation step. Since these
transformations have struggled to introduce N-rich heteroaryl groups stereoselectively – a task for which radical-
mediated migrations hold particular promise – this approach will unlock access to a broad range of stereodefined
carbonyls bearing these privileged pharmacophores, in addition to α- and β-amino acids.
Public Health Relevance Statement
Project Narrative
The proposed research aims to develop new synthetic methods that will improve access to critical materials for
the discovery and manufacture of medicinal agents. These methods will include (a) olefin difunctionalizations to
rapidly convert simple and abundant chemical feedstocks into complex skeletons and pharmacophores, and (b)
stereoselective α-functionalizations of carbonyls to generate novel amino acids and medicinal products and
intermediates. Owing to their “radical-mediated migration” mechanisms that have significant latent potential,
these new approaches will afford clear advances in pharmaceutical synthesis by enabling reactions with
improved stereocontrol and a significantly expanded range of medicinally valuable motifs they can access.
No Sub Projects information available for 1R35GM155233-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM155233-01
Patents
No Patents information available for 1R35GM155233-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM155233-01
Clinical Studies
No Clinical Studies information available for 1R35GM155233-01
News and More
Related News Releases
No news release information available for 1R35GM155233-01
History
No Historical information available for 1R35GM155233-01
Similar Projects
No Similar Projects information available for 1R35GM155233-01